Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Clinical Diagnosis

Reliability and reproducibility of etarfolatide as a folate receptor (FR)-targeted diagnostic imaging agent

Edwin Palmer, James Scott and James Symanowski
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 400;
Edwin Palmer
1Radiology, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Scott
1Radiology, Massachusetts General Hospital, Boston, MA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Symanowski
2Cancer Biostatistics, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 54 no. supplement 2 400

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2013

Author Information

  1. Edwin Palmer1,
  2. James Scott1 and
  3. James Symanowski2
  1. 1Radiology, Massachusetts General Hospital, Boston, MA
  2. 2Cancer Biostatistics, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2015 to April 2025

AbstractFullPdf
May 2015300
Jul 2015100
Sep 2015200
Jan 2016600
Mar 2016100
Jul 2016100
Aug 2016200
Sep 2016200
Jan 2017300
Feb 2017200
Mar 2017100
Apr 2017600
May 2017300
Jun 2017200
Aug 2017400
Sep 2017100
Oct 2017200
Nov 2017200
Dec 2017200
Feb 2018100
Apr 2018800
May 2018500
Oct 2018100
Nov 2018300
Dec 2018100
Jan 2019200
Feb 2019100
Apr 2019100
Aug 2019300
Nov 2019200
Mar 2020100
Apr 2020200
May 2020100
Aug 2020400
Nov 2020100
Dec 2020100
Feb 20211300
Mar 20211000
Apr 2021800
May 20211000
Jun 20211200
Jul 2021900
Aug 2021800
Sep 2021400
Oct 2021200
Nov 2021900
Dec 2021300
Jan 2022200
Feb 2022300
Mar 2022200
Apr 2022300
May 2022200
Jun 2022200
Aug 2022100
Nov 2022100
Dec 2022100
Jan 2023100
Feb 2023200
Mar 2023200
Apr 2023100
May 2023200
Jun 2023100
Jul 2023100
Aug 2023200
Sep 2023200
Oct 2023500
Nov 2023200
Dec 2023300
Jan 2024200
Feb 2024100
Mar 2024200
Apr 2024100
May 2024300
Jun 2024100
Jul 20245000
Aug 20245400
Sep 20241400
Oct 2024100
Nov 2024400
Dec 2024100
Jan 2025200
Feb 2025400
Apr 2025700
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reliability and reproducibility of etarfolatide as a folate receptor (FR)-targeted diagnostic imaging agent
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Reliability and reproducibility of etarfolatide as a folate receptor (FR)-targeted diagnostic imaging agent
Edwin Palmer, James Scott, James Symanowski
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 400;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Reliability and reproducibility of etarfolatide as a folate receptor (FR)-targeted diagnostic imaging agent
Edwin Palmer, James Scott, James Symanowski
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 400;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Clinical Diagnosis

  • Additional value of PSMA-PET/CT in biochemical recurrence during follow-up of patients with prostate cancer.
  • Thymic epithelial tumors: Can FDG PET help in predicting histologic type and stage?
  • Interim FDG-PET/CT Interpreted with Qualitative Visual Trichotomous Assessment Criteria Predict Treatment Failure in Diffuse Large B-cell Lymphoma Treated with R-CHOP
Show more Oncology: Clinical Diagnosis

Molecular Imaging of Gynecological Malignancies

  • Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer
  • Prospective evaluation of simultaneous PET/MRI and PET/CT in cervical cancer
Show more Molecular Imaging of Gynecological Malignancies

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire